company background image
ODI logo

ODI Pharma NGM:ODI Stock Report

Last Price

SEK 2.42

Market Cap

SEK 38.5m

7D

2.5%

1Y

-60.3%

Updated

10 Mar, 2025

Data

Company Financials

ODI Stock Overview

A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. More details

ODI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

ODI Pharma AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for ODI Pharma
Historical stock prices
Current Share PriceSEK 2.42
52 Week HighSEK 8.15
52 Week LowSEK 2.08
Beta0.61
1 Month Change-24.38%
3 Month Change-19.87%
1 Year Change-60.33%
3 Year Change-51.60%
5 Year Change-40.10%
Change since IPO-71.66%

Recent News & Updates

Recent updates

Shareholder Returns

ODISE PharmaceuticalsSE Market
7D2.5%-11.2%-2.6%
1Y-60.3%0.3%7.1%

Return vs Industry: ODI underperformed the Swedish Pharmaceuticals industry which returned 3.4% over the past year.

Return vs Market: ODI underperformed the Swedish Market which returned 8.2% over the past year.

Price Volatility

Is ODI's price volatile compared to industry and market?
ODI volatility
ODI Average Weekly Movement15.4%
Pharmaceuticals Industry Average Movement10.0%
Market Average Movement6.0%
10% most volatile stocks in SE Market13.1%
10% least volatile stocks in SE Market3.4%

Stable Share Price: ODI's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: ODI's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
20181Jan-Mark Edewaardwww.odipharma.com

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden.

ODI Pharma AB (publ) Fundamentals Summary

How do ODI Pharma's earnings and revenue compare to its market cap?
ODI fundamental statistics
Market capSEK 38.51m
Earnings (TTM)-SEK 4.03m
Revenue (TTM)SEK 21.50m

1.8x

P/S Ratio

-9.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ODI income statement (TTM)
RevenueSEK 21.50m
Cost of RevenueSEK 17.13m
Gross ProfitSEK 4.37m
Other ExpensesSEK 8.40m
Earnings-SEK 4.03m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.25
Gross Margin20.31%
Net Profit Margin-18.74%
Debt/Equity Ratio0%

How did ODI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/10 14:45
End of Day Share Price 2025/03/10 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ODI Pharma AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.